Amniotic Membrane: Can It Have An Impact For DFUs?
- Volume 27 - Issue 3 - March 2014
- 6957 reads
- 2 comments
A Guide To The Unique Properties Of Amniotic Membrane
Amniotic membrane is placental tissue that comes from donated placenta after childbirth. It consists of the innermost layer of tissue that is comprised of a thin epithelial layer, a thick basement membrane and an avascular stroma.2
There are several unique properties of amniotic membrane that make it ideal for wound healing.
• Amniotic membrane has abundant stem cells that one can harvest without moral and ethical concerns.
• Amniotic membrane lacks immunogenicity via a low expression or lack of expression of histocompatibility antigens.
• Amniotic membrane has the ability to produce healing with little to no scarring. Along with the indirect contribution of amniotic membrane’s anti-inflammatory effects, there has been evidence of direct reduction of scarring. Tseng and colleagues demonstrated in a laboratory study that there was a direct anti-scarring action on ocular surface fibroblasts by suppressing transforming growth factor beta (TGF-b).3 The TGF-b is responsible for activation of fibroblasts and by down-regulating this process, there is a reduction and prevention of adhesion and fibrosis.
• Amniotic membrane has the ability to impart anti-inflammatory effects by mediating pro-inflammatory cytokines such as interleukin (IL-6) and TNF-alpha. Tseng and colleagues noted that enzyme-linked immunosorbent assay (ELISA) extracts have high levels of IL-10, which counteracts inflammatory effects.3 In addition, they have found amniotic membrane down-regulates the expression and production of IL-1, and up-regulates interleukin-1 receptor antagonist (IL-1RA).
Given all these properties of amniotic membrane, one can imagine what a great benefit it is to have this type of product available to heal these ever challenging diabetic wounds.
Examining The Different Processes For Preserving Amniotic Tissue
Currently, there are two methods of preserving amniotic tissue, dehydration (Purion, MiMedx) and cryopreservation (CryoTek, Bio-Tissue/Amniox Medical).
The Purion method uses a series of rinsing the amniotic tissue in hypertonic salt solutions and dehydration under elevated temperatures. The concern with this type of processing is that it can lead to the destruction of the very elements of the amniotic membrane that are integral in healing.
The new CryoTek process claims to maintain the structures of amniotic membrane. A recent study not yet published by Tan and coworkers demonstrated histologically that the CryoTek process preserved the extracellular matrix and structural proteins of amniotic membrane.4 However, when evaluating the dehydration method results, the study researchers found the morphology of the tissue was compacted, which implies structural changes to the matrix. In addition, both processes demonstrated the presence of hyaluronan.